SherrieJillDivitoMDPhD
Dermatology • Boston, MAAssociate Physician, Brigham and Women's Hospital Instructor, Harvard Medical School
Dr. Divito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Avenue Louis Pasteur
# 671
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2012 - 2015
Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
University of Pittsburgh School of MedicineClass of 2011
Certifications & Licensure
MA State Medical License 2015 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets.Pranali N Shah, George A Romar, Artür Manukyan, Wei-Che Ko, Pei-Chen Hsieh
The Journal of Clinical Investigation. 2024-07-23 - 14 citationsManagement of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.Marie-Charlotte Brüggen, Sarah Walsh, M Milad Ameri, Natalie Anasiewicz, Emanual Maverakis
JAMA Dermatology. 2024-01-01 - 3 citationsAssessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.Dayan J Li, Gustavo A Velasquez, George A Romar, Elisa M Schunkert, Ruth K Foreman
JAMA Dermatology. 2023-08-01
Journal Articles
- Peripheral Host T Cells Survive Hematopoietic Stem Cell Transplantation and Promote Graft-Versus-Host DiseaseSherrie Divito, MD, The Journal of Clinical Investigation
Press Mentions
Study Highlights Issues with Current Approaches to Identifying Culprit Drug in SJS/TEN CasesJune 29th, 2023- Study Points to Need to Improve Identification of Culprit in SJS/TEN CasesJuly 2nd, 2023
Grant Support
- The Role Of Tolerogenic Dendritic Cells In Islet-Cell Allograft TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
